Pasadena, CA, United States of America

Aiko Umeda

USPTO Granted Patents = 4 


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • North Hollywood, CA (US) (2020 - 2021)
  • Pasadena, CA (US) (2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Aiko Umeda: Innovator in Protein Targeting Agents

Introduction

Aiko Umeda is a notable inventor based in Pasadena, California. He has made significant contributions to the field of biochemistry, particularly in the development of peptide-based technologies. With a total of four patents to his name, Umeda's work focuses on innovative methods for protein targeting and antibody capture.

Latest Patents

Umeda's latest patents include groundbreaking research on cyclic peptides as protein targeting agents. These peptides exhibit activity as protein binding agents and encompass various structural forms, including stereoisomers and pharmaceutically acceptable salts. The methods associated with the preparation and use of these peptides, along with pharmaceutical compositions that incorporate them, are also detailed in his patents. Another significant patent involves the development of stable peptide-based antibody capture agents. This application outlines methods for using these agents in detection and diagnosis, as well as manufacturing techniques utilizing iterative on-bead in situ click chemistry.

Career Highlights

Aiko Umeda is affiliated with the California Institute of Technology, where he continues to advance his research in peptide technologies. His work has garnered attention for its potential applications in therapeutic and diagnostic fields.

Collaborations

Umeda collaborates with esteemed colleagues, including James R. Heath and Rosemary Dyane Rohde. Their combined expertise contributes to the innovative research being conducted at their institution.

Conclusion

Aiko Umeda's contributions to the field of biochemistry through his patents and research are noteworthy. His work on peptide-based technologies holds promise for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…